Somatostatin-based therapies for external gastrointestinal fistulas: Updated meta-analysis of randomized clinical trials

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 111889
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.111889

Full Size Figure Download Figure

Figure 6 Surgical intervention for fistula or complications: Somatostatin vs control. RR: Risk ratio.

Citation: Ribeiro Junior MAF, Fontenelle Vieira L, Thalib HI, Fouzaan Albeez S, Heba Fakruddin F, Mirza Zafar Baig A, Mohammed H, Nafeesa Hashim S, Rauf Khan AA, Dib Possiedi R. Somatostatin-based therapies for external gastrointestinal fistulas: Updated meta-analysis of randomized clinical trials. World J Gastrointest Pharmacol Ther 2025; 16(4): 111889
URL: https://www.wjgnet.com/2150-5349/full/v16/i4/111889.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.111889

Ribeiro Junior MAF, Fontenelle Vieira L, Thalib HI, Fouzaan Albeez S, Heba Fakruddin F, Mirza Zafar Baig A, Mohammed H, Nafeesa Hashim S, Rauf Khan AA, Dib Possiedi R. Somatostatin-based therapies for external gastrointestinal fistulas: Updated meta-analysis of randomized clinical trials. World J Gastrointest Pharmacol Ther 2025; 16(4): 111889 [PMID: 41378069 DOI: 10.4292/wjgpt.v16.i4.111889]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.